Double Anaerobic Threshold in Athletes
Evaluation of the Presence of a Double Anaerobic Threshold in a Population of Athletes
1 other identifier
observational
100
1 country
3
Brief Summary
During an incremental cardiopulmonary exercise test (CPET) performed with a ramp protocol, it is very important to determine the anaerobic threshold, defined as the point at which the metabolism switches from being predominantly aerobic to also being anaerobic. The anaerobic threshold can be determined invasively, by identifying the increase in blood lactates with an arterial sampling, or, more commonly, non-invasively by three methods: the V-slope method, the ventilatory equivalents method and by using end-expiratory oxygen and carbon dioxide pressure (PETO2 and PETCO2 respectively). Normally, the anaerobic threshold is determined by the first method and the other two are used to confirm the value. The finding of different anaerobic threshold values using these three methods has been reported anecdotally in the past, while a prevalence of 11% in a healthy population has recently been described. Regular training, particularly that aimed at endurance sports, is able to shift the anaerobic threshold to higher exercise intensities. At present, the physiological reasons for the presence of a double threshold are unclear. The aim of the study is to identify the anaerobic threshold by means of the V-slope method and by means of the ventilatory equivalents method in athletes who have performed an incremental ramp CPET at the laboratories of the investigating centres, to assess in how many athletes a double threshold is present and to try to interpret the physiological/ pathophysiological significance of this finding. In this retrospective and prospective observational study, healthy male and female athletes who have had a cardiopulmonary test at our laboratories from 2007 to the present (retrospectively recruited) and prospectively recruited until the calculated sample size is reached will be enrolled.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2022
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 15, 2022
CompletedFirst Submitted
Initial submission to the registry
February 21, 2023
CompletedFirst Posted
Study publicly available on registry
March 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2023
CompletedMarch 15, 2023
February 1, 2023
1.7 years
February 21, 2023
March 2, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Athletes groups
Identification of two groups of athletes (those with identified double anaerobic threshold and those without)
immediately after the incremental cardiopulmonary exercise test evaluation
Secondary Outcomes (9)
Groups differences in age
immediately after the incremental cardiopulmonary exercise test evaluation
Groups differences in sport practised
immediately after the incremental cardiopulmonary exercise test evaluation
Groups differences in exercise performance
immediately after the incremental cardiopulmonary exercise test evaluation
Groups differences in VO2
immediately after the incremental cardiopulmonary exercise test evaluation
Groups differences in VE/VCO2 slope
immediately after the incremental cardiopulmonary exercise test evaluation
- +4 more secondary outcomes
Eligibility Criteria
Healthy male and female athletes who performed a cardiopulmonary test at our laboratories from 2007 to the present (retrospectively recruited) and prospectively recruited will be enrolled
You may qualify if:
- no major present or past illnesses, no ongoing treatment
- At least 2 training sessions per week.
You may not qualify if:
- Current illnesses and treatments for any physical condition that could potentially alter performance
- Subjects who have performed a submaximal test (RER \< 1.05)
- CPET during which the AT determination is poorly assessable, i.e. due to changes in respiration.
- obese subjects (BMI \>30)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Centro Cardiologico Monzinolead
- Azienda Ospedaliero-Universitaria Careggicollaborator
- University of Foggiacollaborator
Study Sites (3)
Azienda Ospedaliero-Universitaria Careggi
Florence, Italy
University of Foggia
Foggia, Italy
Centro Cardiologico Monzino
Milan, 20138, Italy
Study Officials
- PRINCIPAL INVESTIGATOR
Piergiuseppe Agostoni, Prof.
Centro Cardiologico Monzino
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 21, 2023
First Posted
March 15, 2023
Study Start
March 15, 2022
Primary Completion
December 1, 2023
Study Completion
December 1, 2023
Last Updated
March 15, 2023
Record last verified: 2023-02